Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods. | Biophys Rev | 2022 | 36249860 | PubTator, text mining | PubMed |
| SARS-COV-2 Notable Mutations and Variants: A Review Article. | Iran J Public Health | 2022 | 36248293 | PubTator, text mining | PubMed |
| The evolving epidemiology of monkeypox virus. | Cytokine Growth Factor Rev | 2022 | 36244878 | PubTator, text mining | PubMed |
| Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities. | Immunobiology | 2022 | 36244092 | PubTator, text mining | PubMed |
| Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines. | NPJ Vaccines | 2022 | 36243743 | PubTator, text mining | PubMed |
| Design Strategies for and Stability of mRNA-Lipid Nanoparticle COVID-19 Vaccines. | Polymers (Basel) | 2022 | 36236141 | PubTator, text mining | PubMed |
| Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development. | Int J Mol Sci | 2022 | 36232307 | PubTator, text mining | PubMed |
| In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2. | Hum Immunol | 2022 | 36229378 | PubTator, text mining | PubMed |
| Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | Front Mol Biosci | 2022 | 36225252 | PubTator, text mining | PubMed |
| SERINC5 restricts influenza virus infectivity. | PLoS Pathog | 2022 | 36223419 | PubTator, text mining | PubMed |
| SARS-CoV-2 Envelope Protein Forms Clustered Pentamers in Lipid Bilayers. | Biochemistry | 2022 | 36219675 | PubTator, text mining | PubMed |
| In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease. | J Mol Model | 2022 | 36205801 | PubTator, text mining | PubMed |
| Time-dependent contraction of the SARS-CoV-2-specific T-cell responses in convalescent individuals. | J Allergy Clin Immunol Glob | 2022 | 36203479 | PubTator, text mining | PubMed |
| Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV. | Sci Rep | 2022 | 36195643 | PubTator, text mining | PubMed |
| Genomic and structural mechanistic insight to reveal the differential infectivity of omicron and other variants of concern. | Comput Biol Med | 2022 | 36195045 | PubTator, text mining | PubMed |
| Innate and adaptive immune evasion by dengue virus. | Front Cell Infect Microbiol | 2022 | 36189361 | PubTator, text mining | PubMed |
| Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments. | Front Pharmacol | 2022 | 36188605 | PubTator, text mining | PubMed |
| Viral inactivation by light. | eLight | 2022 | 36187558 | PubTator, text mining | PubMed |
| Genomic and evolutionary study from SARS-CoV-2 virus isolates from Bangladesh during the early stage of pandemic strongly correlate with European origin and not with China. | Genomics | 2022 | 36182010 | PubTator, text mining | PubMed |
| Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion. | Food Chem Toxicol | 2022 | 36179993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=41